Business
GT Biopharma Inc (NASDAQ: GTBP) Have Inclined 5.08% YTD, Forecasting What Will Happen Next
GT Biopharma Inc (NASDAQ:GTBP)’s traded shares stood at 0.13 million during the last session, with the company’s beta value hitting 1.37. At the close of
